Medinice (WAR:ICE) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


WAR:ICE Medinice SA WAR:ICE
24 GF Score
Price zł69.00
GF Value zł0.99
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medinice Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Medinice's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

WAR:ICE vs ABT, SYK, MDT: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Medinice's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medinice Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medinice's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Medinice's Margin of Safety % (DCF Earnings Based) falls into.


WAR:ICE
24GF Score
Medinice SA WAR:ICE
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medinice (WAR:ICE) Overvalued in 2026?

Based on GuruFocus' analysis, Medinice stock appears to be overvalued. The current stock price of zł69.00 is trading 6869.7% above its estimated GF Value™ of zł0.99. GuruFocus considers Medinice to be Significantly Overvalued.

Key valuation signals for WAR:ICE:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: zł0.99 vs. price of zł69.00 (6869.7% above fair value)
  • GF Score™: 24/100 with 2 warning signs

No single metric tells the full story. See the WAR:ICE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medinice Business Description

Other Exchanges 77E:Germany
Address Hankiewicza Street 2, Warszawa, POL, 02-103
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.
24GF Score

Get the complete analysis for WAR:ICE

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł69.00
Price
zł0.99
GF Value